Description: Halberd Corporation researches and develops antibodies and devices for the prevention, detection, and treatment of Covid-19 through laboratory, hospital, and clinical trials. It offers patented extracorporeal treatment that is applicable to various blood-borne and neurologic diseases, including Covid-19, other viruses, PTSD, cancer, etc. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
Home Page: halberdcorporation.com
PO Box 25
Jackson Center,
PA
16133
United States
Phone:
814 786 8849
Officers
| Name | Title |
|---|---|
| Mr. William A. Hartman | Pres, CEO & Chairman |
| Mr. John S. Borza AVS, MBA, PE | COO & Director |
| Ms. Heidi H. Carl | Director & Accounting Director |
| Dr. Mitchell S. Felder M.D. | CTO & Member of the Scientific Advisory Board |
| Dr. Patricio F. Reyes FAAN, M.D. | Chief Mechanical Officer & Member of the Scientific Advisory Board |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.7333 |
| Price-to-Book MRQ: | 16.9035 |
| Price-to-Sales TTM: | 267.7955 |
| IPO Date: | |
| Fiscal Year End: | July |
| Full Time Employees: | 0 |